Latest Changes

Title Description Major Minor Date
Ceftolozane-tazobactam rationale document published 2020/05/15
EUCAST 2019 - 20. The chairmanĀ“s report. The EUCAST General Committee meeting at ECCMID 2020 was cancelled due to COVID19. The EUCAST Steering Committee and subcommittees have, under the heading of the traditional ChairmanĀ“s report, summarised the last 12 months of activity. 2020/05/04
Cefiderocol breakpoints and AST methods Addendum to the EUCAST breakpoint table v 10.0: Cefiderocol breakpoints and AST methods (30 April, 2020) 2020/04/30
Rationale documents for amikacin, gentamicin and tobramycin updated 2020/04/30
EUCAST position paper on daptomycin in Enterococcal blood stream infections and endocarditis. Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper Clinical Microbiology and Infection, 2020. 2020/04/28
Warnings against gradient tests for piperacillin-tazobactam removed 2020/04/24
Aminoglycoside guidance document updated The guidance document on aminoglycoside dosing, first published 21 Jan, 2020, was updated 24 April, 2020. 2020/04/24
Temocillin breakpoints published 2020/04/21
Temocillin rationale document published 2020/04/21
RAST breakpoint table v 2.1 (as a substitute for 2.0) published Because of an error in the tab E. faecalis, a corrected version 2.1 is published. The only change is in the E.F faecalis tab. 2020/04/20
Aminoglycoside MIC distributions and ECOFFs reviewed in accordance with SOP 10.1 2020/04/12
EUCAST instruction videos with Romanian subtitles 2020/04/07
Daptomycin and temocillin MIC data and ECOFFs reviewed 2020/04/06
EUCAST advice on intrinsic resistance and unusual phenotypes updated. 2020/03/03
EUCAST broth microdilution reading guide updated EUCAST broth microdilution reading guide updated to version 2.0 with specific reading instructions for Gram-negative organisms with tigecycline and eravacycline added. 2020/03/02
Quality of 21 brands of commercially available MH powders EUCAST has evaluated the quality of 21 Mueller Hinton powders, all commercially available. Several media performed well together with EUCAST criteria whereas others performed poorly. 2020/02/29
AFST - updated breakpoint tables 2020/02/25
AFST QC tables updated 2020/02/25
Rationale documents for antifungal agents updated 2020/02/17
Update: Breakpoint tables for Rapid AST directly from blood culture bottles 2020/02/10
RAST from blood culture bottles published 2020/02/05
New version of the ECOFFinder program available 2020/01/26
Guidance on the implementation and use of the 2020 revised aminoglycoside breakpoints (Jan 21, 2020) 2020/01/21
EUCAST/CLSI joint working group recommendations on the determination of appropriate disk content Consultation document with comments and responses published 2020/01/10
Guidance on Topical agents Revised guidance not on breakpoints for topical agents (valid from the 1 January, 2020) 2019/12/31
VetCast update on Steering Committee information 2019/12/30
EUCAST 2020 breakpoint tables available 2019/12/20
Updated guidance on methodological documents (disk testing, reading guide, media preparation) 2019/12/20
Consultation on ceftolozane-tazobactam concluded. Comments and EUCAST response released. 2019/12/13
EUCAST respons to comments during the temocillin consultation 2019/12/09
EUCAST Breakpoint table v 10.0 for consultation 2019/12/06
SOPs updated SOPs 1, 2, 5, 6 and 10 updated. 2019/12/04
Frequently Asked Questions - Mycobacteria A file with questions and answers was added 2019/11/27
ECOFFs for ceftolozane and ceftolozane-tazobactam added. 2019/11/25
Updated warnings Updated warnings and a new warning against the use of gradient tests for benzylpenicillin in S. pneumoniae issued. 2019/11/21
Workshop on generating phenotypic susceptibility data on MTBC 2019/11/19
Expert rules Enterococcus The document stated: "High level resistance reflect production of ANT(6) or other enzymes or of ribosomal mutations. In vitro studies have shown lack of synergy of betalactams and gentamicin (now corrected to streptomycin) in such strains." 2019/11/07
General consultation on revised ceftolozane-tazobactam breakpoints 2019/11/01
Cefazolin breakpoints in Enterobacterales in UTI - consultation until 8 November, 2019. 2019/10/24
Updated website statistics The use of EUCAST web pages reflects the adoption of EUCAST recommendations. Website statistics are updated on a regular basis. 2019/10/17
Frequently Asked Questions on EUCAST RAST 2019/10/15
Temocillin clinical breakpoints - consultation General consultation until 8 November, 2019, on proposed temocillin clinical breakpoints 2019/10/14
Two new instruction videos available EUCAST has just published two new instruction videos - one on the storage and handling of disks and media, and one on QC of AST in the laboratory. 2019/10/07
AFST Rationale Documents and new breakpoint table for consultation. 2019/09/25
Rationale for the reference method for MIC determination of M. tuberculosis New document on the "Rationale for the reference method for MIC determination of M. tuberculosis" posted 2019/09/03
Florefenicol RD v 1.0 published by VetCAST 2019/08/16
FAQ document updated. The EUCAST FAQ document has been updated. Several new Q and A on S, I and R definitions and the use of ATUs. 2019/08/12
B. pseudomallei breakpoints and methods - comments and response to consultation 2019/07/23
Comments and EUCAST responses to the consultation on following through on the change to "Susceptible, increased exposure". Consultation on "Susceptible, increased exposure" with comments and EUCAST responses, now available. 2019/07/22
Antimycobacterial susceptibility testing Several changes - rationale documents for bedaquiline and delaminide published, consultation finalised, and a reference method for MIC testing of Mycobacteria published. 2019/07/19